Articles

More than ever with the disjointed health care so prevalent in our nation, our patients need us.

Become That Someone for Your Patients

Overall growth in specialty pharmacy today is significantly outpacing traditional pharmacies and soon will make up approximately half of total pharmacy spend.

Understanding Specialty Pharmacy (Part 1)

Are we doing enough to protect those on the front lines? 

Protecting Pharmacists: The PPE Every COVID-19 Vaccinator Needs Now

“If some among you fear taking a stand because you are afraid of reprisals from customers, clients, or even government, recognize that you are just feeding the crocodile hoping he’ll eat you last.” – Ronald Reagan

Advocate for Your Pharmacy Staff

“We have met the enemy, and they are ours!”

Pharmacists Must Unify to Overcome Challenges in Profession

Expert Interviews

Stephen Schondelmeyer, PharmD, Drug Topics editorial advisory board member, discusses pharmacy highlights from 2020, and where he sees pharmacy headed in 2021.

Year in Review and 2021 Pharmacy Trends: COVID-19 Impacts, PBM Accountability

Ken Thai, PharmD, Drug Topics editorial advisory board member, lists the key trends from 2020 and where he envisions pharmacy going in 2021.

Year in Review and 2021 Pharmacy Trends with Ken Thai

Lakesha Butler, PharmD, Drug Topics editorial advisory board member, examines 2020 trends in diversity, equity and inclusion within health care and explores the year ahead. 

Year in Review and 2021 Pharmacy Trends: Diversity, Equity, and Inclusion

Technology will help you identify potential reimbursement problems before they trigger reduced payments or claims audits.

Using Data to Put a Stop to Your Pharmacy's Profit Leakage

Pharmacists go beyond merely dispensing drugs to provide higher levels of care.

Clinical Skills Help Pharmacists Emphasize Their Value to Patients

Poll

Todd Mizeski, Esq, a Partner in Frier Levitt’s Life Sciences, Litigation Department, discusses the case of Rutledge v. Pharmaceutical Care Management Association.

US Supreme Court Hears Argument on State’s Ability to Regulate PBMs

By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.

How Rare Cannabinoids Are Disrupting the Pharmaceutical Industry

Doug Hoey is CEO, National Community Pharmacists Association.

Policymakers have the power to get pharmacy benefit managers under control. 

Opinion: PBM Hocus Pocus Harming Seniors, Small Business Pharmacies

If anything has demonstrated the need and value of expanded access to community-based care, it’s been the coronavirus disease 2019 pandemic. 



Celebrate and Advocate for the Pharmacy Profession

In the absence of rock-solid data to the contrary, wearing a mask seems to be a small sacrifice to protect each other’s health.

Mask Wearing: A Small Sacrifice for the Greater Good

Unfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.

Misdosing: More Common Than You Think 

Pharmacy technicians work alongside pharmacists to meet unprecedented demands during these times. They are not expendable.

Pharmacy Employees: Essential Workers Amid Pandemic but Often Overlooked

Why do we pharmacists buy generics from foreign manufacturers? The answer is pure and simple: the cost. 

 To “Buy American” Generic Drugs, Pharmacists Must Be Adequately Reimbursed

How pharmacists can address knowledge gaps and health literacy challenges to help people with chronic conditions stay adherent to drug therapies

Why Patient Education Is More Important Than Ever

“I just hope that pharmacists’ judgment can soon be a contributing factor in pharmacotherapy decisions made by PBMs and insurance companies.”

Viewpoints